Back to Search

GEORGE TIDMARSH, M.D.

M.D.

Neonatal-Perinatal Medicine Physician

NPI: 1427502186Individual

Specialties, Licenses & Credentials

Neonatal-Perinatal Medicine PhysicianPrimary

Pediatrics — Neonatal-Perinatal Medicine

Code: 2080N0001X

G68589(CA)

Research & Publications (10)

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
PMID 19188061·Eur J Cancer·2009
3-trial
Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.
PMID 18337683·Q J Nucl Med Mol Imaging·2009
3-trial
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
PMID 17661038·Cancer Chemother Pharmacol·2008
3-trial
A novel alkylating agent, glufosfamide, enhances the activity of gemcitabine in vitro and in vivo.
PMID 17786181·Neoplasia·2007
4-observational
Liposomal doxorubicin and the accelerated approval process.
PMID 17538184·J Clin Oncol·2007
8-other
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
PMID 16110029·J Clin Oncol·2005
3-trial
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
PMID 14729604·Cancer Res·2004
7-preclinical
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
PMID 11579112·J Clin Oncol·2001
3-trial
Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience.
PMID 10942366·Blood·2000
3-trial
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.
PMID 10715303·J Clin Oncol·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
10182 TELESIS CT
SAN DIEGO, CA 92121

Quick Facts

NPI
1427502186
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
10

Are you this provider?

Claim Your Profile